Deal Announcements

Anaphore Adds $39 Million VC Financing

Tuesday, October 11, 2011 5:32:00 AM PDT | VentureDeal Staff

   La Jolla, California  --  Biotechnology company Anaphore has secured $39.9 million in new venture capital investment, according to an SEC regulatory filing.

Anaphore says that it is developing treatments focused on immune-based diseases.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1